Cancer Vaccines
Research on cancer vaccines detailed by scientists at National Heart Lung and Blood Institute
Published in Cancer Weekly, February 5th, 2008
New investigation results, 'Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies,' are detailed in a study published in Blood. "We describe the safety and immunogenicity of a combined vaccine of 2 leukemia-associated antigenic peptides, PR1 and WT1. Eight patients with myeloid malignancies received one subcutaneous dose each of PR1 and WT1 vaccines in Montanide adjuvant, with granulocyte-macrophage colony-stimulating factor," scientists writing in the journal Blood report.
"Patients were reviewed weekly for 4 weeks to monitor toxicity and immunologic responses....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-02-05)
More Articles from Cancer Weekly
- Cancer Vaccines
Newly discovered virus linked to deadly skin cancer - Better Health Publishing
Breakthrough Study Links Prostate Cancer, Depression, IBS, Adrenal Fatigue and Allergies to Lead and Mercury Toxic Load in Body - Biophysics
New biophysics study findings recently were reported by J.M. Escoffre and co-researchers - Cancer Gene Therapy
Study data from Sichuan University provide new insights into cancer gene therapy - Cancer Vaccines
Research from A. Pallecarosa et al has provided new information about cancer vaccines - Cancer Vaccines
Research from S.I. Liu and co-researchers yields new findings on cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
